Insulin Sensitivity
208
23
33
131
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
23 trials with published results (11%)
Research Maturity
131 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
11 terminated out of 208 trials
92.3%
+5.7% vs benchmark
5%
11 trials in Phase 3/4
18%
23 of 131 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 131 completed trials
Clinical Trials (208)
Aging Resilience Through Microbiota Optimization and Regulation
Diaplex and Glycemic Control
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
Fructose: Substrate, Stimulus, or Both?
Antecedent Metabolic Health and Metformin Aging Study
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Acute Microbial Switch
Saccharin and Acesulfame Potassium Consumption and Glucose Homeostasis in Older Adults With Prediabetes
Evaluation of Molecular Hydrogen Supplementation to Enhance the Efficacy of Weight Loss Retreat in Overweight and Obese Adolescents
Improving Sleep Health and Circadian Timing to Support Cardiometabolic Health in Adolescents
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance
Sucralose and Glucose Metabolism in Young Healthy Adults
Low Dose Fat-Induced Insulin Resistance
Metabolic Adaptations to Weight Loss With and Without Exercise
The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight
Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling
Activity, Adiposity, and Appetite in Adolescents 2 Intervention
Ultra-processed Food Consumption, Gut Microbiota, and Glucose Homeostasis
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation